{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:17:21Z","timestamp":1790399841607,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jpba.2021.114102","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T12:35:55Z","timestamp":1619440555000},"page":"114102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["NOX2 inhibitor GSK2795039 metabolite identification towards drug optimization"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3794-9389","authenticated-orcid":false,"given":"Elias Carvalho","family":"Padilha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0076-7159","authenticated-orcid":false,"given":"Pranav","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9763-9641","authenticated-orcid":false,"given":"Ganesha","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jpba.2021.114102_bib0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling","volume":"24","author":"Ray","year":"2012","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.jpba.2021.114102_bib0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.jpba.2021.114102_bib0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1152\/physrev.1998.78.2.547","article-title":"The free radical theory of aging matures","volume":"78","author":"Beckman","year":"1998","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.jpba.2021.114102_bib0020","doi-asserted-by":"crossref","first-page":"H24","DOI":"10.1152\/ajpheart.00799.2009","article-title":"Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-\/- mice","volume":"298","author":"Judkins","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"32","key":"10.1016\/j.jpba.2021.114102_bib0025","doi-asserted-by":"crossref","first-page":"12132","DOI":"10.1073\/pnas.0603670103","article-title":"The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice","volume":"103","author":"Wu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jpba.2021.114102_bib0030","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative stress in neurodegenerative diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.jpba.2021.114102_bib0035","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s11064-020-02987-3","article-title":"An effective NADPH oxidase 2 inhibitor provides neuroprotection and improves functional outcomes in animal model of traumatic brain injury","volume":"45","author":"Wang","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jpba.2021.114102_bib0040","article-title":"Pyrroloquinoline quinone inhibits oxidative stress in rats with diabetic nephropathy","volume":"26","author":"Zhang","year":"2020","journal-title":"Med. Sci. Monit."},{"issue":"5","key":"10.1016\/j.jpba.2021.114102_bib0045","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1089\/ars.2014.6202","article-title":"Discovery of GSK2795039, a novel small molecule NADPH oxidase 2 inhibitor","volume":"23","author":"Hirano","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.jpba.2021.114102_bib0050","doi-asserted-by":"crossref","first-page":"18852","DOI":"10.1038\/s41598-019-55189-5","article-title":"VAS2870 and VAS3947 attenuate platelet activation and thrombus formation via a NOX-independent pathway downstream of PKC","volume":"9","author":"Lu","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jpba.2021.114102_bib0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/17460441.2019.1569625","article-title":"Strategies to optimize drug half-life in lead candidate identification","volume":"14","author":"Broccatelli","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jpba.2021.114102_bib0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fphar.2019.00234","article-title":"Application of in vitro drug metabolism studies in chemical structure optimization for the treatment of fibrodysplasia ossificans progressiva (FOP)","volume":"10","author":"Padilha","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"24","key":"10.1016\/j.jpba.2021.114102_bib0065","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/jm100888d","article-title":"Aldehyde oxidase: an enzyme of emerging importance in drug discovery","volume":"53","author":"Pryde","year":"2010","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jpba.2021.114102_bib0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13321-020-00426-7","article-title":"Predicting liver cytosol stability of small molecules","volume":"12","author":"Shah","year":"2020","journal-title":"J. Cheminform."},{"issue":"3","key":"10.1016\/j.jpba.2021.114102_bib0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/03602532.2011.560606","article-title":"Increasing recognition of the importance of aldehyde oxidase in drug development and discovery","volume":"43","author":"Garattini","year":"2011","journal-title":"Drug Metab. Rev."},{"issue":"24","key":"10.1016\/j.jpba.2021.114102_bib0080","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1021\/acs.jmedchem.9b00875","article-title":"Metabolism by aldehyde oxidase: drug design and complementary approaches to challenges in drug discovery","volume":"62","author":"Manevski","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jpba.2021.114102_bib0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/mutage\/gev082","article-title":"The utility of metabolic activation mixtures containing human hepatic post-mitochondrial supernatant (S9) for in vitro genetic toxicity assessment","volume":"31","author":"Cox","year":"2016","journal-title":"Mutagenesis"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521002132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521002132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:14:28Z","timestamp":1760001268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521002132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":17,"alternative-id":["S0731708521002132"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114102","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NOX2 inhibitor GSK2795039 metabolite identification towards drug optimization","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114102"}}